Primary Sclerosing Cholangitis Pipeline Review, H2 2012 New Report
Primary Sclerosing Cholangitis - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Primary Sclerosing Cholangitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Primary Sclerosing Cholangitis.
View full press release